Page 33 - ப்ரிஸ்க்ரிப்ஶந் மருந்து பயனர் கட்டணம் நாடகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article NEW YORK, May 18, 2021 /PRNewswire/  Pomerantz LLP announces that a class action lawsuit has been filed against Kadmon Holdings, Inc. ( Kadmon or the Company ) (NASDAQ: KDMN) and certain of its officers.  The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-01797, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired  Kadmon securities between October 1, 2020 and March 10, 2021, both dates inclusive (the Class Period ), seeking to recover damages caused by Defendants violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

New yorkUnited statesFrance generalLos angelesAbrahaml pomerantzRoberts willoughbyKadmon holdings incUnited states district courtSecurities exchangeDrug administrationPomerantz firmKadmon holdingsEastern districtSecurities exchange actClass periodLead plaintiff